Picchio Gaston 4
4 · Arbutus Biopharma Corp · Filed Sep 25, 2020
Insider Transaction Report
Form 4
Picchio Gaston
Chief Development Officer
Transactions
- Award
Common Stock
2020-09-23+50,000→ 50,000 totalExercise: $3.35Exp: 2020-02-17→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on February 14, 2020, the trading day immediately preceding the date the performance based option grant wasapproved by the Executive Compensation and Human Resources Committee of the Board of Directors (the "Committee") of Arbutus Biopharma Corporation, subject to both shareholder approval of anamendment to the Registrant's 2016 Omnibus Share and Incentive Plan (the "Plan Amendment") and the fulfillment of certain performance criteria.
- [F2]The Registrant's shareholders approved the Plan Amendment on May 28, 2020. On September 23, 2020, the Committee determined that the performance criteria had been met.